Aeglea BioTherapeutics | Investor Presentation Deck | 37 slides · page 24 of 37
The slide uses a biological pathway diagram to explain the mechanism of action of the drug candidate.
Pitch deck · solution · present_solution · balanced density
Slide locked Sign in to view
Slide schematic 4/4
callout 1/1 diagram 1/1 source-note 1/1 title 1/1
Components 4
primary value-chain source-note headline
Tools 0
∅
No tools
No canon tool match is anchored to this slide.
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 1